Status: Not yet recruiting
SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma
The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability and efficacy of SCTB35 and SCTB41 With or Without Chemotherapy in non-Hodgkin's lymphoma patients.
Participants needed: 90
Trial details
Phase: Phase 1, Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Sinocelltech Ltd.Updated: Sep 14, 2026Locations: 1
Eligibility criteria
Aged 18 to 80 years (inclusive) at the time of informed consent [+6]
Prior treatment with bispecific antibodies targeting both CD20 and CD3 [+5]